Our Vision
Provide more effective and safer vaccines to fight infectious diseases important for animal and human health.
Pan Genome Systems Focus on livestock (cattle, camels, sheep, goats) and Poultry Health Products. We also help other strategic partners in testing their products.
What We Do
Pan Genome Systems develops and delivers novel, patent-protected vaccines and diagnostics directed to control Johne’s disease in Cattle, Avian Influenza and Avian Coronavirus (Infectious Bronchitis Virus) in Poultry. We also provide research services to help others in developing their own products after signing the appropriate agreements.
Pan Genome Systems' products and services are helpful to other researchers, farmers, technicians, veterinarians and veterinary labs.
We treat every customer as our partner. Our success is your success.
Pan Genome Systems' products are born of world-class science. Our core technology has been developed and honed over 15 years of laboratory research, and commercial development.
Our Product Promise
Safe
The safety of our products is paramount. We have carefully created products with both animals and farmers in mind, putting product safety first.
Simple
Our single-dose vaccines are easily administered on the farm and maximize protection while reducing workload for busy farmers.
Effective
Detailed studies, in the laboratory, in controlled conditions, and in the field, have proven the effectiveness of our products to reduce infections, reduce disease spread, and reduce side-effects.
Proven
Our products have been subject to the most rigorous of laboratory and field testing by world-leading scientists, industry experts, and real farmers over years of product testing and development.
Our People
Management Team
Board of Directors
Dr. Adel Talaat, Ph.D Chairman/CEO
Dr. Bill Checovich, Ph.D Board Member
Dr. Mike Collins, Ph.D Board Member
News
Pan Genome Systems to Present at Wisconsin Early Stage Symposium on November 12-13th in Madison, WI
Pan Genome Systems was announced as a presenting company in the Wisconsin Angel Network Investors’ Track at the upcoming Wisconsin Early Stage Symposium on November 12-13th at the Monona Terrace Community and Convention Center in Madison, Wisconsin. The symposium is organized and run by the Wisconsin Technology Council. At the symposium, Pan Genome Systems will pitch its technology against other…
PGS successfully test a new vaccine against Johne’s disease (or Paratuberculosis)
This new vaccine was 100% effective when tested in goats. This vaccine could work as well in sheep and cattle. See the full details in the following article. Superior Protection from Live-Attenuated Vaccines Directed against Johne’s Disease. Shippy DC1, Lemke JJ, Berry A, Nelson K, Hines ME 2nd, Talaat AM5. Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00478-16. doi: 10.1128/CVI.00478-16. https://cvi.asm.org/content/24/1/e00478-16.long
PGS develops a novel protective vaccine against different strains of chicken Influenza
PGS used a propriety mosaic sequence of multiples isolates of highly pathogenic isolates of Avian Influenza to develop a protective vaccine with almost sterilizing immunity that can benefit poultry flocks. This vaccine targets both low and high pathogenicity isolates of Avian Influenza. See the details in the following article: Effective mosaic-based nanovaccines against avian influenza…
PGS develop a novel vaccine that is safe and effective to control paratuberculosis
See the following article for published in a premier nature group journal, Vaccines. A single dose polyanhydride-based nanovaccine against paratuberculosis infection. Thukral, A., K. Ross, C. Hansen, Y. Phanse, B. Narasimhan, H. Steinberg and A. M. Talaat (2020). npj Vaccines 5(1): 15. https://www.nature.com/articles/s41541-020-0164-y
Patents:
Inventor: Adel M. Talaat, Bassam Abomoelak and Sarah K. Ward. Immunogenic Compositions Against Tuberculosis. US 8,367,055 B2. (Issued)
Inventor: Adel M. Talaat. Vaccine Candidates Against Johne’s Disease. US 8,758,77
(Issued)
Inventor: Adel M. Talaat. Global gene regulators (GGR) as vaccine candidates against paratuberculosis. US 10,544,389 (Issued)
Inventor: Adel M. Talaat. RNA Biomarkers for Early Diagnosis of Mycobacterial Infections. WARF: P130075US01 (Pending)
Inventor: Adel M. Talaat and Sekar Chandrasekar. WARFplex: A novel adjuvant for animal and human vaccines. WARF: P190189 (Pending).
Inventor: Adel M. Talaat and Brock Bakke. A universal vaccine against Infectious Bronchitis Virus, Avian Influenza, Newcastle Disease Virus and Infectious Bursal Disease. WARF: P190239 (Pending).